Status:
COMPLETED
Comparison of Fenofibric Acid Bioavailability From ABT-335 Capsules
Lead Sponsor:
Abbott
Conditions:
Healthy
Eligibility:
All Genders
18-55 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to evaluate the safety and compare the bioavailability of fenofibric acid from 2 different dosage strengths of ABT-335.
Eligibility Criteria
Inclusion
- A condition of general good health
- BMI 18 to 29
Exclusion
- Currently enrolled in another clinical study
- Females who are pregnant or breast-feeding
Key Trial Info
Start Date :
February 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT00839293
Start Date
February 1 2009
Last Update
October 15 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Site Reference ID/Investigator# 16862
Waukegan, Illinois, United States, 60085